These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3034311)

  • 1. Evaluation of carcinoembryonic antigen and periodic acid-Schiff stains in the diagnosis of serous and mucinous ovarian tumors: morphometrical study.
    Aalto ML; Selkäinaho K; Collan Y
    Appl Pathol; 1986; 4(1-2):83-9. PubMed ID: 3034311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
    Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of PAS-diastase and carcinoembryonic antigen staining in the differential diagnosis of malignant mesothelioma and papillary serous carcinoma of the ovary.
    Silcocks PB; Herbert A; Wright DH
    J Pathol; 1986 Jun; 149(2):133-41. PubMed ID: 2426430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
    Ayhan A; Guven S; Guven ES; Kucukali T
    Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of epithelial membrane antigen in the diagnosis of ovarian tumors.
    Fujimoto I; Hirai Y; Hasumi K; Masubuchi K; Osamura Y
    Acta Cytol; 1990; 34(4):549-54. PubMed ID: 1695804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
    Oishi T; Maruo T; Iwasaki M; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodic acid-Schiff stain as a prognostic indicator in serous and mucinous ovarian tumors.
    Aalto ML; Collan Y
    Int J Gynaecol Obstet; 1986 Feb; 24(1):27-34. PubMed ID: 2874066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms.
    Goldstein NS; Bassi D; Uzieblo A
    Am J Clin Pathol; 2001 Aug; 116(2):246-52. PubMed ID: 11488072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borderline epithelial tumors of the ovary.
    Hart WR
    Mod Pathol; 2005 Feb; 18 Suppl 2():S33-50. PubMed ID: 15761465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen in human ovarian neoplasms.
    Marchand A; Fenoglio CM; Pascal R; Richart RM; Bennett S
    Cancer Res; 1975 Dec; 35(12):3807-10. PubMed ID: 1192434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine differentiation in ovarian mucinous tumors.
    Jiang C; Tan Y; Li E; Zhang D
    Chin Med J (Engl); 2000 Jan; 113(1):70-4. PubMed ID: 11775215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosubstances in classification of serous and mucinous ovarian tumors: a morphometrical study.
    Aalto ML
    Eur J Obstet Gynecol Reprod Biol; 1986 Jul; 22(3):139-44. PubMed ID: 3732584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen in primary and metastatic ovarian tumors.
    Fleuren GJ; Nap M
    Gynecol Oncol; 1988 Jul; 30(3):407-15. PubMed ID: 2839395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian tumors of low malignant potential (borderline tumors): immune morphology and current status.
    Neunteufel W; Gitsch G; Schieder K; Kölbl H; Breitenecker G
    Anticancer Res; 1989; 9(4):993-7. PubMed ID: 2684001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential).
    Scully RE
    Bull Cancer; 1982; 69(3):228-38. PubMed ID: 6289947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of biochemical markers between benign and malignant ovarian cysts.
    Knight JA; Wu JT; Miya T; Knight DP
    Clin Physiol Biochem; 1986; 4(2):130-5. PubMed ID: 3516514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localisation of carcinoembryonic antigen (CEA) in malignant epithelial ovarian tumours using monoclonal antibodies.
    Gogate N; Deshmukh S
    Indian J Pathol Microbiol; 1995 Apr; 38(2):199-201. PubMed ID: 8919110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the clinical problem: facts and current issues of mucinous cystic neoplasms of the pancreas.
    Jeurnink SM; Vleggaar FP; Siersema PD
    Dig Liver Dis; 2008 Nov; 40(11):837-46. PubMed ID: 18499541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.
    Mok SC; Bell DA; Knapp RC; Fishbaugh PM; Welch WR; Muto MG; Berkowitz RS; Tsao SW
    Cancer Res; 1993 Apr; 53(7):1489-92. PubMed ID: 8384077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.